Minim Invasive Neurosurg 2011; 54(3): 132-134
DOI: 10.1055/s-0031-1279717
Case Report

© Georg Thieme Verlag KG Stuttgart · New York

FloSeal Hemostatic Matrix Use for Intraventricular Hemorrhage during a Neuroendoscopic Procedure

A. Reeves1 , M. Muhonen1 , W. Loudon1
  • 1Department of Neurosurgery, University of California Irvine, Orange, California, USA
Further Information

Publication History

Publication Date:
23 August 2011 (online)

Abstract

Introduction: Neuroendoscopy is a rapidly growing field, but the risk of intraventricular hemorrhage is signficant. There are few novel ways of obtaining hemostasis for major hemorrhage described in the literature.

Patient: A 5-year-old boy with a history of intraventricular hemorrhage and multi-cystic hydrocephalus presented with worsening brainstem compression from dilation of a 4th ventricle cyst.

Results: During endoscopic surgery to fenestrate the cyst, arterial hemorrhage was emergently controlled with the hemostatic agent, FloSeal.

Conclusion: To the best of the authors’ knowledge, this is the first report of a patient with intraoperative intraventricular hemorrhage controlled with FloSeal.

References

  • 1 Ellegala DB, Maartens NF, Laws Jr ER. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.  Neurosurgery. 2002;  51 513-515 discussion 515–516
  • 2 Cappabianca P, Esposito F, Esposito I. et al . Use of a thrombin-gelatin haemostatic matrix in endoscopic endonasal extended approaches: technical note.  Acta Neurochir (Wien). 2009;  151 69-77 discussion 77
  • 3 Oz MC, Cosgrove 3rd DM, Badduke BR. et al . Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group.  Ann Thorac Surg. 2000;  69 1376-1382
  • 4 Renkens Jr KL, Payner TD, Leipzig TJ. et al . A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery.  Spine. 2001;  26 1645-1650
  • 5 Weaver FA, Hood DB, Zatina M. et al . Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.  Ann Vasc Surg. 2002;  16 286-293
  • 6 Gazzeri R, Galarza M, Neroni M. et al . Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage.  J Neurosurg. 2009;  110 939-942
  • 7 Fiss I, Danne M, Stendel R. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.  Neurol Med Chir (Tokyo). 2007;  47 462-467

Correspondence

A. Reeves

Department of Neurosurgery

University of California Irvine

101 The City Drive South

Orange

California 92868

USA

Phone: +1/714/456 6966

Fax: +1/714/456 8212

Email: alreeves@uci.edu